arrow
S

Srikanth Kotapati

Bristol Myers Squibb Company
H指数:15
被引数:546

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design and Characterization of Prodrugged Anti-CTLA-4 Antibodies

Prodrugged Anti-CTLA-4 Antibodies的设计与表征

2025-07-080
PREAI
Discovery and Characterization of a First-in-Class LIV1-TLR7/8 Immunomodulatory Conjugate with Robust Myeloid Activation and Antitumor Activity

发现并表征了一种具有强效髓系细胞激活和抗肿瘤活性的首创LIV1-TLR7/8免疫调节偶联物

2025-05-240
OA
Targeted Delivery of TLR7 Agonists to the Tumor Microenvironment Enhances Tumor Immunity via Activation of Tumor-Resident Myeloid Cells

将TLR7激动剂靶向递送至肿瘤微环境通过激活肿瘤驻留骨髓细胞增强肿瘤免疫

2025-02-130
PRE
Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model
2022-03-0312
OAAI
DNA-Model-Based Design and Execution of Some Fused Benzodiazepine Hybrid Payloads for Antibody-Drug Conjugate Modality
2021-02-103
OA
Design, Synthesis, and Structure-Activity Relationships of Novel Tetrahydroisoquinolino Benzodiazepine Dimer Antitumor Agents and Their Application in Antibody-Drug Conjugates
2020-11-0611
PREAI
Universal Affinity Capture Liquid Chromatography-Mass Spectrometry Assay for Evaluation of Biotransformation of Site-Specific Antibody Drug Conjugates in Preclinical Studies
2019-12-2024
PREAI